Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,617.00    9.00 (0.35%)
Bid:
2,619.00
Ask:
2,620.00
Spread: 1.00 (0.038%)
Market Cap: £23.19b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Directorate Change

21 Dec 2017 10:00

RNS Number : 0587A
Experian plc
21 December 2017
 

Experian plc

 

 

Directorate Change

 

 

21 December 2017 - Experian, the global information services company, announces the appointment of a new independent Non-Executive Director to the Board of Experian plc, effective from 1 April 2018.

 

Dr. Ruba Borno, 36, a US national, is a member of the Executive Leadership Team at Cisco, the worldwide technology leader delivering solutions to help securely connect digital business. In her role at Cisco, she helps guide strategy and leads priority initiatives across key partnerships, technology and investment strategies. Ruba is central to informing Cisco's digital and business transformation and that of its customers and partners.

 

Holding a Ph.D. and a Master of Science in Electrical Engineering, and a Bachelor of Science in Computer Engineering, Ruba was an Intel Ph.D. fellow at the National Science Foundation's Engineering Research Center for Wireless Integrated MicroSystems. She sits on the board of The Tech Museum of Innovation in Silicon Valley. Ruba was previously at The Boston Consulting Group (BCG) where she specialised in helping enterprises through complex technology transformations, and was a leader in BCG's Technology, Media & Telecommunications, and People & Organization practice groups.

 

Don Robert, Chairman of Experian, commented:

 

"I am very pleased to welcome Ruba Borno to the Board of Experian. Ruba will bring advanced technologies expertise, and the Board and Experian will also benefit greatly from her focus on supporting businesses in strategically adapting to the threats and opportunities created by technology, as well as pushing disruptive technology to create new opportunities. We will also benefit from her insight and understanding of digitisation and technology transformation across industries."

 

The Company confirms that there are no details to be disclosed under Listing Rule 9.6.13R, paragraphs (1) to (6).

 

Contacts

 

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4215

Gerry Tschopp Media queries

 

Finsbury

Rollo Head +44 (0)20 7251 3801

Jenny Davey

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 16,000 people operating across 37 countries and every day we're investing in new technologies, talented people and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOATBBLTMBTTMAR
Date   Source Headline
30th May 20175:06 pmRNSTransaction in Own Shares
26th May 20174:46 pmRNSTransaction in Own Shares
25th May 20175:27 pmRNSTransaction in Own Shares
23rd May 20175:11 pmRNSTransaction in Own Shares
22nd May 20175:20 pmRNSTransaction in Own Shares
22nd May 20172:46 pmRNSDirector/PDMR Shareholding
22nd May 201711:31 amRNSBond Issue
18th May 20174:33 pmRNSTransaction in Own Shares
18th May 20171:00 pmRNSShare repurchases
18th May 20177:00 amRNSPreliminary results for year ended 31 March 2017
28th Apr 20172:28 pmRNSTotal Voting Rights
18th Apr 20175:22 pmRNSTransaction in Own Shares
13th Apr 20172:00 pmRNSDirector/PDMR Shareholding
11th Apr 20175:19 pmRNSTransaction in Own Shares
7th Apr 20175:20 pmRNSTransaction in Own Shares
6th Apr 20175:41 pmRNSTransaction in Own Shares
5th Apr 20175:19 pmRNSTransaction in Own Shares
3rd Apr 20179:00 amRNSExperian agrees to sell Email/CCM business
31st Mar 201710:33 amRNSTotal Voting Rights
16th Mar 20179:10 amRNSBlock listing Interim Review
10th Mar 20173:15 pmRNSDirector/PDMR Shareholding
28th Feb 20175:33 pmRNSTransaction in Own Shares
28th Feb 201712:59 pmRNSIrrevocable and non-discretionary arrangement
28th Feb 201710:18 amRNSTotal Voting Rights
27th Feb 20178:30 amRNSDirector Declaration
3rd Feb 20175:04 pmRNSTransaction in Own Shares
2nd Feb 20175:28 pmRNSTransaction in Own Shares
1st Feb 20175:37 pmRNSTransaction in Own Shares
1st Feb 20179:44 amRNSAdditional Listing
31st Jan 20175:04 pmRNSTransaction in Own Shares
31st Jan 20179:30 amRNSTotal Voting Rights
30th Jan 20175:17 pmRNSTransaction in Own Shares
27th Jan 20175:00 pmRNSTransaction in Own Shares
26th Jan 20175:12 pmRNSTransaction in Own Shares
25th Jan 20175:15 pmRNSTransaction in Own Shares
25th Jan 20172:45 pmRNSDirector/PDMR Shareholding
24th Jan 20175:28 pmRNSTransaction in Own Shares
23rd Jan 20175:57 pmRNSTransaction in Own Shares - Replacement
23rd Jan 20174:54 pmRNSTransaction in Own Shares
20th Jan 20174:50 pmRNSTransaction in Own Shares
19th Jan 20172:44 pmRNSTransaction in Own Shares
18th Jan 20173:05 pmRNSTransaction in Own Shares
18th Jan 20177:00 amRNSTrading update, third quarter
6th Jan 20175:30 pmRNSFirst interim dividend
30th Dec 20161:25 pmRNSTotal Voting Rights
30th Dec 201610:00 amRNSShare buy-back programme
14th Dec 20165:48 pmRNSTransaction in Own Shares
14th Dec 201611:10 amRNSAdditional Listing
13th Dec 20165:30 pmRNSTransaction in Own Shares
12th Dec 20165:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.